Company / R&D per Share
Xtant Medical Holdings, Inc. R&D per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$0.02
FY2025
5-year range
$0.01 / $0.02
FY2021-FY2025
Trend
+67.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
R&D per Share has fluctuated over the past 10 years, ranging from $0.01 in FY2023 to $2.37 in FY2017.
Based on SEC 10-K filings.
0.02 in FY2025 with a 5-year CAGR of -24.7%.
Improved from $0.01 to $0.02 over the past 2 years.
R&D per Share over time
Growth rates
- 3-Year CAGR
- +19.7%
- 5-Year CAGR
- -24.7%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, r&d per share increased 67.1% year-over-year.
- Peak r&d per share was recorded in FY2017.
- Lowest r&d per share in the period was in FY2023.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.02 | +67.1% |
| FY2024 | $0.01 | +22.1% |
| FY2023 | $0.01 | -15.9% |
| FY2022 | $0.01 | +18.0% |
| FY2021 | $0.01 | -88.0% |
| FY2020 | $0.07 | -45.2% |
| FY2019 | $0.13 | -92.0% |
| FY2018 | $1.61 | -32.1% |
| FY2017 | $2.37 | +1008.6% |
| FY2016 | $0.21 | -0.9% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026